AMOXYCILLIN 250 MG in pharma franchise in Tamil Nadu

AMOXYCILLIN 250 MG in PCD pharma franchise in Mumbai

AMOXYCILLIN 250 MG in top pharma company in Nagaland

AMOXYCILLIN 250 MG in pcd pharma supplier in Vadodara

AMOXYCILLIN 250 MG in phama franchise company in india
AMOXYCILLIN 250 MG in phama distributor in Raipur

Home/Products /amoxycillin-250-mg-dispersible-tablet

Moxyplit 250 DT Tablet

Composition : Amoxicillin 250mg Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹72/-

Moxyplit 250 DT Tablet is a broad-spectrum antibiotic containing Amoxycillin 250 mg in a dispersible tablet form, ensuring easy administration, especially for pediatric and elderly patients. Amoxycillin belongs to the penicillin group of antibiotics and works by inhibiting bacterial cell wall synthesis, leading to the destruction of harmful bacteria.

This medication is highly effective against a variety of bacterial infections affecting the respiratory tract, urinary tract, ear, nose, throat, skin, and soft tissues. It is commonly used in treating tonsillitis, bronchitis, pneumonia, and sinusitis, as well as infections caused by susceptible Gram-positive and Gram-negative bacteria.

The dispersible formulation allows the tablet to dissolve quickly in water, making it a convenient option for patients who have difficulty swallowing pills. It is known for its high absorption rate and rapid onset of action, ensuring effective bacterial eradication and faster recovery.

Moxyplit 250 DT Tablet should be taken as prescribed by a healthcare provider, and the full course must be completed even if symptoms improve earlier, to prevent antibiotic resistance.

Read More

About the Product

Moxyplit 250 DT Tablet is a broad-spectrum antibiotic containing Amoxycillin 250 mg in a dispersible tablet form, ensuring easy administration, especially for pediatric and elderly patients. Amoxycillin belongs to the penicillin group of antibiotics and works by inhibiting bacterial cell wall synthesis, leading to the destruction of harmful bacteria.

This medication is highly effective against a variety of bacterial infections affecting the respiratory tract, urinary tract, ear, nose, throat, skin, and soft tissues. It is commonly used in treating tonsillitis, bronchitis, pneumonia, and sinusitis, as well as infections caused by susceptible Gram-positive and Gram-negative bacteria.

The dispersible formulation allows the tablet to dissolve quickly in water, making it a convenient option for patients who have difficulty swallowing pills. It is known for its high absorption rate and rapid onset of action, ensuring effective bacterial eradication and faster recovery.

Moxyplit 250 DT Tablet should be taken as prescribed by a healthcare provider, and the full course must be completed even if symptoms improve earlier, to prevent antibiotic resistance.

Common side effects may include nausea, diarrhea, vomiting, skin rash, and mild allergic reactions.

Used for treating bacterial infections of the respiratory tract, urinary tract, skin, soft tissues, and ear, nose, and throat (ENT) infections.

Take the full course of treatment as directed by a healthcare professional to prevent antibiotic resistance and recurrence of infection.

Store in a cool, dry place, away from direct heat and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation